Navigation Links
Tobira Therapeutics Announces Presentation of TBR-652 Data at European AIDS Conference
Date:11/12/2009

PRINCETON, N.J. and SAN DIEGO, Nov. 12 /PRNewswire/ -- Tobira Therapeutics, a clinical stage biotechnology company committed to research and product discovery for the treatment of life-threatening and life-altering infectious diseases, today announced pharmacokinetic data and results from two double-blind, placebo-controlled studies of TBR-652 in eighty-four healthy volunteers. The two studies, a single-ascending dose (SAD) study and the multiple-ascending dose (MAD) study, were undertaken to assess the pharmacokinetics, safety and tolerability of TBR-652 in two tablet formulations under fasted and fed conditions, respectively. In the SAD study 2 cohorts of 12 subjects were randomized per dose level; each subject received up to 3 single escalating doses of study drug. Dosing followed an overnight fast of at least 8 hours. In the MAD study, 5 dose groups of 12 subjects each were randomized to receive drug daily for 10 days. Doses were either in the same formulation as the SAD study (F1) or a newer formulation (F2). Doses were taken within 10 minutes after completion of a standard high-fat breakfast. Subjects in both studies were followed for 10 days after the last dose of TBR-652.

TBR-652 was readily absorbed in both tablet formulations achieving mean peak plasma concentrations in 4-6 hours. A 25 mg/day F1 or F2 tablet achieved plasma exposures greater than the target therapeutic level of 2ng/mL projected from in vitro studies of TBR-652. TBR-652 was eliminated from plasma with linear kinetics and similar half-lives (mean approximately 35-40 hours) across dose levels. This elimination half-life is sufficiently long to support once-daily dosing.

TBR-652 was well-tolerated at single daily doses up to 800 mg and once-daily doses of up to 200 mg for 10 days. Headache, diarrhea, abdominal pain and nausea were the most commonly encountered treatment-emergent events; all AEs resolved by the end of both studies. "The results fro
'/>"/>

SOURCE Tobira Therapeutics Inc.
Copyright©2009 PR Newswire.
All rights reserved

Page: 1 2

Related medicine technology :

1. Tobira Therapeutics Inc. Announces In Vitro Data of TBR-652 for the Treatment of HIV
2. Tobira Therapeutics Inc. Receives US Patent for TBR-652
3. Reportlinker Adds Pain Therapeutics 2005: Market Dynamics and Outlook
4. Oxygen Biotherapeutics, Inc. Announces 1:15 Reverse Stock Split to Take Effect Nov. 9, 2009
5. Trius Therapeutics Files Registration Statement for Proposed Initial Public Offering
6. Orexigen(R) Therapeutics Announces Third Quarter 2009 Financial Results
7. Echo Therapeutics Initiates Clinical Study of its New One-Piece Symphony(TM) tCGM Biosensor in Type 1 and Type 2 Diabetic Patients
8. Echo Therapeutics Announces Significant Advance in Development of its One-Piece, Needle Free Symphony tCGM Biosensor
9. Orexigen(R) Therapeutics Releases New Efficacy Data for Contrave(R) in Late Breaker Presentations at the 27th Annual Scientific Meeting of The Obesity Society
10. Logical Therapeutics Announces Positive Results of LT-NS001 vs. Naproxen Clinical Study
11. Horizon Therapeutics Presents Phase 3 Study Results Identifying Risk Factors for Ulcer Development Among NSAID Users
Post Your Comments:
*Name:
*Comment:
*Email:
(Date:3/27/2015)... Report Details  New study shows ... What does the future hold for top companies ... new report shows you potential revenues to 2025, assessing ... 242-page report provides 185 tables, charts, and graphs. Discover ... future market prospects. Our new study lets you assess ...
(Date:3/27/2015)... Wis. , March 27, 2015 ... unit shipments of incontinence devices for women. ... but the most gratifying part is the hundreds ... from women whose lives have been positively impacted ... president of InControl. InControl recently released ...
(Date:3/27/2015)... , March 27, 2015  RXi ... privately-held MirImmune LLC, today announced that they ... to RXi,s novel and proprietary sd-rxRNA® technology ... immunotherapies. The collaboration has the potential to ... friendly cancer treatments that could be a ...
Breaking Medicine Technology:Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 2Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 3Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 4Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 5Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 6Pharma Leader Series: Top 25 Ophthalmic Drug Manufacturers 2015-2025 7InControl Medical Surpasses 40,000 Shipments Of Incontinence Devices For Women 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 2RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 3RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 4RXi Pharmaceuticals and MirImmune LLC Enter into an Exclusive Licensing Agreement for RXi's Self-Delivering RNAi (sd-rxRNA) Technology to Develop Cell-based Immunotherapies to Treat Cancer 5
... Feb. 8, 2011 Targetbase ... for its expertise in understanding consumer data, translating that ... creative with measurable results, today announced that Peter Dannenfelser ... - Healthcare.  Dannenfelser, a pharmaceutical marketing executive with extensive ...
... Canon announced today at MD&M West in Anaheim that it ... build on its success since its 2010 launch. As part ... (CDM) database product will become part of Qmed, the world,s ... medical device OEMs. As part of the new alignment, the ...
Cached Medicine Technology:Peter Dannenfelser Joins Targetbase as Vice President of Strategy, Bringing 15 Years of Pharmaceutical Marketing Experience 2Peter Dannenfelser Joins Targetbase as Vice President of Strategy, Bringing 15 Years of Pharmaceutical Marketing Experience 3UBM Canon Announces Significant Investment and Development Plans for the Next Generation of Qmed.com 2UBM Canon Announces Significant Investment and Development Plans for the Next Generation of Qmed.com 3
(Date:3/27/2015)... CT (PRWEB) March 27, 2015 Trail mix ... after a workout, on weekend hikes and during the game! ... benefits. Aurora Natural is proud to introduce a new line ... taste buds. Deliciously rich and flavorful selections packed with nutritious, ... seeds, dried fruit and grains that add protein and fiber ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 Since September 2014, ... in his comeback tour after having been in retirement for ... eager for the performer to return to touring, and concert ... tickets for Omaha will likely sell out for the two ... BuyCheapTicketsToEvents.com to view the inventory of discounted Garth ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 April 2015 is ... – the Sesquicentennial. To honor America’s bloodiest war and the ... Adams Trust presents A Tribute to the Civil War and ... Friday, April 17, 2015, at the Jane Pickens Theater in ... Civil War-Lincoln scholar, will serve as the master of ceremonies. ...
(Date:3/27/2015)... (PRWEB) March 27, 2015 In light ... (case number 1:15-cv-10429, U.S. District Court, District of Massachusetts; ... the Eastern District of Pennsylvania), the San Diego personal ... Helbock, A.P.C. are announcing that they are available to ... of women who were prescribed Zofran while pregnant and ...
(Date:3/26/2015)... 26, 2015 Let’s not lose focus ... produce are today’s traffic magnets. Three out of 4 ... of their produce department, according to a Packaged Facts ... people are looking to add more fruits and vegetables ... Manager® Day is April 2. As featured in the ...
Breaking Medicine News(10 mins):Health News:Aurora Product, Inc. Introduces New Line of Specialty Trail Mixes 2Health News:Garth Brooks Tickets for Omaha: BuyCheapTicketsToEvents.com Draws Customers by Discounting Prices on 2015 Tickets for Garth Brooks’ Tour Stops at CenturyLink Center 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 2Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 3Health News:Relive the Civil War, the Presidency and Shocking Assassination of Abraham Lincoln through Lincoln’s Own Words and the Music of a 46-Piece Orchestra 4Health News:The Law Office of Melinda J. Helbock, A.P.C. Announces That It Is Now Accepting Case Reviews for Potential Zofran Birth Defect Lawsuits 2
... ... since January; 2.4 million generic prescriptions filled with no copay; Customers have until June 30,2009 ... ... and Blue Shield of North Carolina (BCBSNC) is helping customers save money and stay ...
... Products Earn Mention in New Stop Growing Older ... Grow ... his just released book "Stop Growing Older ... Grow Younger," ... the multi-billion-dollar anti-aging industry. Throughout the pages of this resource, ... advocating instead an all-natural approach to slowing down the aging ...
... Recession In Nation,s Largest Effort to ,Stamp Out Hunger, ... difficult economic times throughout the nation, Americans donated a ... Letter Carriers National Food Drive to restock community food ... to combat hunger, the National Association of Letter Carriers ...
... hire 22 percent fewer college graduates in 2009 than they ... and Employers (NACE). That means thousands of South Carolina college ... health insurance coverage. , , BlueCross BlueShield of South ... health care coverage while they continue to try to land ...
... ORLANDO - When combined with standard chemotherapy, an international ... therapy vandetanib improves progression-free survival for patients with advanced ... University of Texas M. D. Anderson Cancer Center. ... Clinical Oncology,s annual meeting, mark the first clinical benefit ...
... Darryl Y. Sue, MD, an investigator at the Los ... & Yvette Dadone Clinical Teaching Award for his "sustained excellence ... School of Medicine at the University of California, Los Angeles ... The award he is receiving is presented to teachers who ...
Cached Medicine News:Health News:BCBSNC Customers Save Millions and Stay on Medications with Free Generics Program 2Health News:BCBSNC Customers Save Millions and Stay on Medications with Free Generics Program 3Health News:Explorer's Bounty Coffees and Chocolates Helping Individuals Reverse the Aging Process 2Health News:Record 73.4 Million Pounds Collected in Letter Carriers' National Food Drive 2Health News:S.C. BlueCross Makes Coverage Available for Thousands of South Carolina Graduates Lacking Health Insurance 2Health News:Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 2Health News:Vandetanib shows clinical benefit when combined with docetaxel for lung cancer 3Health News:LA BioMed researcher receives clinical teaching award 2
... The first instrumentation ... efficiently manage the ... Proven technology automatically ... collates cassettes sequentially. ...
Shandon MicroWriter™ I Cassette Labeler is a permanent cassette marking system....
Fully modular system for long-term storage. Available as complete five-drawer system or as individual components....
Space-saving storage cabinets for microscope slides....
Medicine Products: